The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023) will be held 24-27 September 2023 in Oslo, Norway. IATDMCT 2023 will be the most important opportunity for experts in Therapeutic Drug Monitoring and Clinical Toxicology from the world to meet and discuss the innovations and problems in the field.

Registration to the congress is now open. The deadline for early bird registration is June 15th. You will find the registration fees favorable as the local NOK is weak toward most other currencies.

Accommodation for the congress: See info on the congress website. Please note that the hotels in central Oslo are popular, so you are advised to book early. Search among the many hotel options in central Oslo by your favorite hotel booking website; this gives you the most favorable pricing. Descriptions correspond well with realities, so you have the opportunity to select according to your own requirements and price level.

Program details are currently also being updated on the website. The IATDMCT 2023 Congress offers an attractive opportunity for sponsors to interact with the attendees, and present their company, products and services. Please visit the website of congress for more details if you are interested in sponsors.

We are looking forward to seeing you in Oslo in September!

Stein Bergan (Congress Chair)

http://iatdmct2023.org/       IATDMCT@gyro.no

Please visit the official website http://iatdmct2023.org/ to know more details about the requirements of abstracts. Feel free to email IATDMCT@gyro.no if you have questions related to this Congress.

The special Membership Award includes free membership to IATDMCT & access to the TDM journal – period of 2 years, renewable once. Any IATDMCT member in good standing may nominate an individual from a designated developing country who is unable to afford the annual membership dues and Journal subscription. Applications should be submitted to the management office by October 31 of the year preceding the Award year.

Enjoy all the valuable Membership Benefits, including online access to the Therapeutic Drug Monitoring (TDM) journal.

Get the complete Terms of Reference and learn how to apply today.

Deadline: July 31, 2023

At the 2023 IATDMCT Congress in Oslo, the venue for the 2027 Congress will be chosen.

Members interested in submitting a proposal to host the Congress must submit an application by July 31, 2023. The purpose of this application is to provide guidance for candidates and to facilitate the task of selecting the final site, for the Site Selection Committee. You may choose to submit the information required on the application form in a different format, but all questions on the form should be addressed. Very often a tourism office, conference center, or hotel in the region can help you gather the information.

For more information on the application process, please contact: Congress Site Selection Committee

Click here to email your questions

Join us in maintaining the IATDMCT membership! We look forward to inspiring many further colleagues who share with us the idea of an optimized and personalized drug treatment to join us in IATDMCT. Please ensure you renew your membership in order to retain your IATDMCT member benefits.

Our 2023 Member-Get-A Member Campaign now is up and running! Members are invited to inform their colleagues (who are not members yet) about the benefits of membership. Let’s build a strong partnership together!

Campaign Deadline: August 31, 2023.

The top recruiter (with at least 50%-paying members) will gain a free registration for the IATDMCT Congress 2023 in Oslo.

Click here for complete participation details!

Interview with Amy Rieborn

To complement last month’s podcast (‘We can work it out!’), we reached out to Amy Rieborn, a PhD student working with Teun Van Gelder and Dirk Jan Moes on various projects involving anticancer drugs. It was really a pleasure to hear about this innovative body of work. Amy started out as a medical doctor and became interested in the TDM of anticancer drugs after wondering why it is so little used in this context compared to the antimicrobials we often see monitored. I’m impressed with the breadth of her work that covers a variety of anticancer drug classes, including hormonal agents, kinase inhibitors and monoclonal antibodies. It was also great to hear about the clinical use of microsampling for home-based monitoring of immunosuppressants. Another great interview from a bright Young Scientist who will no doubt achieve big things.

Read more

Find the latest news and follow our IATDMCT institutional page on LinkedIn, Twitter @IATDMCT or Instagram!

Stay ahead with the latest scientific research developments in the fields of TDM and CT!

The monthly Therapeutic Drug Monitoring column provides you with the latest posts of ahead-of-print. Bringing to you articles posted online April 14 – 20, 2023:

ORIGINAL ARTICLE:

• Impact of CYP2D6 Genotype on Paroxetine Serum Concentration
  Hole, Kristine; Haslemo, Tore; Molden, Espen
  March 30, 2023

SHORT COMMUNICATIONS:

• Simultaneous Determination of Rifamycin Antibiotics and Their Active Metabolites in Human Plasma Using UHPLC-MS/MS to Evaluate Their Impact on Target Peak Concentrations: A Short Communication
  Wu, Ling-jie; Ye, Zhen-jie; Zhang, Xiao-ying; Zhang, Xiao-long; Zheng, Ai-xian; Liu, Xiao-long; Yu, Xiao-ling Less
  April 14, 2023
• An Optimized LC-MS/MS Method for Quantification of Sunitinib and N-Desethyl Sunitinib in Human Plasma and Its Application for Therapeutic Drug Monitoring
  Li, Qiaoqiao; Tang, Tiantian; Zhang, Min; Li, Lixian; Chen, Wanyi Less
  April 14, 2023

››Submit your high quality research – Information for authors.

We are inviting members interested to join Communication Committee to assist in the management of Social Media (Twitter, Instagram and LinkedIn) and Website.

Please send an email to Dr. Ofelia Noceti (ofelianp@gmail.com) and Dr. Ryuji Kato (ryuji.kato@ompu.ac.jp), which include a resumed CV and explanatory note telling which area you would like to cooperate. We are looking forward to your candidates!

» Click here to Post an Event on our Online Events Calendar today!

Visit the IATDMCT Events Calendar and stay informed about the upcoming TDM and CT Meetings. By doing this you can comfortably and directly reach all related online resources.

June 24-28, 2023; Bellevue, Washington
Website: https://researchsocietyonalcohol.org/

The Society serves as a meeting ground for scientists and a forum for communication and career development among alcohol researchers. Its goals are to attract and support the next generation of alcohol researchers and to disseminate scientific knowledge regarding alcohol use and alcohol-related problems.

June 24, 2023 is the 17th Charles Lieber & 1st Peter Ferenci Memorial Symposium – Organizers Manuela Neuman and Helmut Seitz.

The 2023 Annual Meeting of American College of Clinical Pharmacology (ACCP) will be held on Sept 10-12,2023 at the Hyatt Regency Bellevue, WA, USA. Looking forward to your participation! Registration is now open.

The 39th annual meeting of the Japanese Society of Therapeutic Drug Monitoring (JSTDM) will be held on June 24th-25th, 2023 (Kyoto, Japan). JSTDM intends to organize the “JSTDM–IATDMCT Joint Symposium 2023 in Asia” as a part of scientific program of the above Congress. This symposium aims to share the latest research on therapeutic drug monitoring and to facilitate interaction between Asian scientists of JSTDM and IATDMCT.

The following three IATDMCT members from Malaysia, Thailand and India will participate in the symposium as speakers.

• Dr. Hannah Abdul Halim (Head of Clinical Pharmacokinetic Services, Pharmacy Department, Hospital Kuala Lumpur, Malaysia)
• Dr. Karunrat Tewthanom (Department of Pharmacy, Silpakorn University, Thailand)
• Dr. Sumith K Mathew (Associate professor, Christian Medical College, Vellore, India)
• Dr. Yasuhiro Horita (Lecturer, Nagoya City University, Nagoya, Japan)

The deadline for registration is May 17.

The IFCC Organization presents a prospect for laboratory professionals and scientists, granting them access to the remarkable scientific program that has been meticulously crafted. Registered participants will have the opportunity to attend all symposia virtually from May 21st to May 25th. We are pleased to announce that virtual registration for this significant event will be available FREE of charge for attendees from low- and middle-income countries. The IFCC Executive Board is thus pleased to warmly invite those who are unable to attend the event in person to register for virtual access.

Co-editor: Manuela Neuman
Co-editor: Ryuji Kato
Co-editor: Miao Yan

NOTE: Items appearing in the IATDMCT monthly E-News do not necessarily have the endorsement of the Association.